Table of Contents
1 Table of Contents 2
1.1 List of Tables 14
1.2 List of Figures 19
2 Introduction 22
2.1 What Is This Report About? 22
3 Executive
Summary 23
4 Definitions of Markets Covered in the Report 24
4.1
Cardiovascular Devices 24
4.2 Cardiac Rhythm Management 24
4.2.1
Cardiac Resynchronisation Therapy 24
4.2.1.1 Cardiac Resynchronisation
Therapy - Defibrillator 24
4.2.1.2 Cardiac Resynchronisation Therapy -
Pacemaker 24
4.2.2 Cardiovascular Pacing and ICD Leads 24
4.2.3
Implantable Cardioverter Defibrillator 25
4.2.3.1 Dual Chamber Implantable
Cardioverter Defibrillator 25
4.2.3.2 Single Chamber Implantable
Cardioverter Defibrillator 25
4.2.4 Pacemaker 25
4.2.4.1 Dual Chamber
Pacemaker 25
4.2.4.2 Single Chamber Pacemaker 25
4.3 Cardiovascular
Monitoring and Diagnostic Devices 25
4.3.1 ECG Monitoring Equipment 25
4.3.2 ECG Stress Testing Systems 26
4.3.3 Event Monitoring Systems 26
4.3.4 Holter Monitoring Systems 26
4.4 Cardiovascular Prosthetic Devices
26
4.4.1 Cardiac Assist Devices 26
4.4.1.1 Intra-Aortic Balloon Pump
26
4.4.1.2 Intra-Aortic Balloon Pump Catheters 26
4.4.1.3 Total
Artificial Heart 26
4.4.1.4 Ventricular Assist Devices 27
4.4.2
Cardiac Valve Repair 27
4.4.3 Prosthetic Heart Valve 27
4.4.3.1
Mechanical Heart Valve 27
4.4.3.2 Tissue Heart Valve 27
4.5
Cardiovascular Surgery 27
4.5.1 Beating Heart Surgery Systems 27
4.5.2
Cardiac Ablation Devices 27
4.5.3 Cardiopulmonary Bypass Equipment 28
4.5.4 Perfusion Disposables 28
4.5.4.1 Custom Packs 28
4.5.4.2
Oxygenators 28
4.6 Electrophysiology 28
4.6.1 Electrophysiology
Ablation Catheter 28
4.6.2 Electrophysiology Diagnostic Catheter 28
4.6.3 Electrophysiology Lab Systems 29
4.7 Interventional Cardiology
29
4.7.1 Arteriotomy Closure Devices 29
4.7.2 Cardiac Catheter 29
4.7.2.1 Angiography Catheter 29
4.7.2.2 Guiding Catheter 29
4.7.3
Coronary Guidewire 29
4.7.4 Coronary Stent 29
4.7.4.1 Bare Metal Stent
30
4.7.4.2 Drug Eluting Stent (DES) 30
4.7.5 PTCA Balloon 30
4.7.5.1 FW Balloon 30
4.7.5.2 Over the Wire Balloon 30
4.7.5.3 Rx
Balloon 30
4.8 Peripheral Vascular Devices 30
4.8.1 Aortic Stent Graft
30
4.8.2 Embolic Protection Devices 31
4.8.3 Inferior Vena Cava Filter
31
4.8.4 Peripheral Guidewire 31
4.8.5 Peripheral Vascular Stent
31
4.8.6 PTA Balloon 31
4.8.7 Synthetic Surgical Grafts 31
5
Healthcare Sector Review 32
5.1 Healthcare Expenditure 32
5.2
Healthcare Infrastructure 33
5.3 Healthcare Policy 38
6 Regulation
System 39
6.1 Medical Equipment Approval Process 39
6.1.1
Classification of medical devices 39
6.1.2 Conformity Assessment Process
48
6.1.2.1 Class I devices 48
6.1.2.2 Class IIa devices 49
6.1.2.3
Class IIb devices 50
6.2 Post Market Surveillance (PMS) 51
7 Pricing
and Reimbursement 52
7.1 Pricing and Reimbursement Policies 52
8
Distribution Structure 53
9 Cardiovascular Devices In Spain 54
9.1
Cardiovascular Devices, Spain, Overall Revenue ($ m), 2000-2015 54
9.2
Cardiovascular Devices, Spain, Category Volume (Units), 2000-2015 58
9.3
Cardiovascular Devices Market, Spain Cross Category Analysis 62
9.4
Cardiovascular Devices, Spain, Company Share (2007-2008) 63
10 Cardiac
Rhythm Management In Spain 64
10.1 Cardiac Rhythm Management Overall
Revenue (2000-2015) 64
10.2 Cardiac Resynchronisation Therapy Overall
Revenue (2000-2015) 67
10.2.1 Implantable Cardioverter Defibrillator
Overall Revenue (2000-2015) 69
10.2.2 Pacemaker Overall Revenue
(2000-2015) 71
10.3 Cardiac Rhythm Management Overall Volume (2000-2015)
73
10.3.1 Cardiac Resynchronisation Therapy Overall Volume (2000-2015)
75
10.3.2 Implantable Cardioverter Defibrillator Overall Volume
(2000-2015) 77
10.4 Pacemaker Overall Volume (2000-2015) 79
10.5
Cardiac Rhythm Management Average Price (2000-2015) 81
10.6 Cardiac Rhythm
Management Market Dynamics 82
10.6.1 Market Drivers 82
10.6.2 Market
Restraints 82
10.7 Cardiac Rhythm Management Distribution Share
(2007-2008) 83
10.8 Cardiac Rhythm Management, Spain, Company Share
(2007-2008) 83
11 Cardiovascular Monitoring and Diagnostic Devices In
Spain 85
11.1 Cardiovascular Monitoring and Diagnostic Devices Overall
Revenue (2000-2015) 85
11.2 Cardiovascular Monitoring and Diagnostic
Devices Overall Volume (2000-2015) 88
11.2.1 Cardiovascular Monitoring and
Diagnostic Devices Average Price (2000-2015) 90
11.3 Cardiovascular
Monitoring & Diagnostic Devices Market Dynamics 91
11.3.1 Market Drivers
91
11.3.2 Market Restraints 91
11.4 Cardiovascular Monitoring and
Diagnostic Devices Distribution Share (2007-2008) 92
11.5 Cardiovascular
Monitoring and Diagnostic Devices, Spain, Company Share (2007-2008) 93
12
Cardiovascular Prosthetic Devices In Spain 94
12.1 Cardiovascular
Prosthetic Devices Overall Revenue (2000-2015) 94
12.1.1 Cardiac Assist
Devices Overall Revenue (2000-2015) 97
12.1.2 Prosthetic Heart Valve
Overall Revenue (2000-2015) 99
12.2 Cardiovascular Prosthetic Devices
Overall Volume (2000-2015) 101
12.2.1 Cardiac Assist Devices Overall
Volume (2000-2015) 103
12.2.2 Prosthetic Heart Valve Overall Volume
(2000-2015) 105
12.3 Cardiovascular Prosthetic Devices Average Price
(2000-2015) 107
12.4 Cardiovascular Prosthetic Devices Market Dynamics
108
12.4.1 Market Drivers 108
12.4.2 Market Restraints 108
12.5
Cardiovascular Prosthetic Devices Distribution Share (2007-2008) 108
12.6
Cardiovascular Prosthetic Devices, Spain, Company Share (2007-2008) 109
13
Cardiovascular Surgery In Spain 110
13.1 Cardiovascular Surgery Overall
Revenue (2000-2015) 110
13.1.1 Perfusion Disposables Overall Revenue
(2000-2015) 112
13.2 Cardiovascular Surgery Overall Volume (2000-2015)
114
13.2.1 Perfusion Disposables Overall Volume (2000-2015) 115
13.3
Cardiovascular Surgery Average Price (2000-2015) 117
13.4 Cardiovascular
Surgery Market Dynamics 118
13.4.1 Market Drivers 118
13.4.2 Market
Restraints 118
13.5 Cardiovascular Surgery Distribution Share (2007-2008)
118
13.6 Cardiovascular Surgery, Spain, Company Share (2007-2008) 119
14 Electrophysiology In Spain 120
14.1 Electrophysiology Overall Revenue
(2000-2015) 120
14.2 Electrophysiology Overall Volume (2000-2015) 122
14.3 Electrophysiology Market Dynamics 123
14.3.1 Market Drivers 123
14.3.2 Market Restraints 123
14.4 Electrophysiology Average Price
(2000-2015) 123
14.5 Electrophysiology Distribution Share (2007-2008)
124
14.6 Electrophysiology, Spain, Company Share (2007-2008) 125
15
Interventional Cardiology In Spain 126
15.1 Interventional Cardiology
Overall Revenue (2000-2015) 126
15.1.1 Cardiac Catheter Overall Revenue
(2000-2015) 129
15.1.2 Coronary Stent Overall Revenue (2000-2015) 131
15.1.3 PTCA Balloon Overall Revenue (2000-2015) 133
15.2 Interventional
Cardiology Overall Volume (2000-2015) 135
15.2.1 Cardiac Catheter Overall
Volume (2000-2015) 137
15.2.2 Coronary Stent Overall Volume (2000-2015)
139
15.2.3 PTCA Balloon Overall Volume (2000-2015) 141
15.3
Interventional Cardiology Average Price (2000-2015) 143
15.4
Interventional Cardiology Market Dynamics 145
15.4.1 Market Drivers
145
15.4.2 Market Restraints 145
15.5 Interventional Cardiology
Distribution Share (2007-2008) 146
15.6 Interventional Cardiology, Spain,
Company Share (2007-2008) 146
16 Peripheral Vascular Devices In Spain
148
16.1 Peripheral Vascular Devices Overall Revenue (2000-2015) 148
16.2 Peripheral Vascular Devices Overall Volume (2000-2015) 152
16.3
Peripheral Vascular Devices Market Dynamics 156
16.3.1 Market Drivers
156
16.3.2 Market Restraints 156
16.4 Peripheral Vascular Devices
Average Price (2000-2015) 157
16.5 Peripheral Vascular Devices
Distribution Share (2007-2008) 158
16.6 Peripheral Vascular Devices,
Spain, Company Share (2007-2008) 159
17 Overview of Key Companies in Spain
Cardiovascular Devices Market 160
17.1 Boston Scientific Corporation
160
17.1.1 Company Overview 160
17.1.2 Value Chain Analysis 161
17.1.2.1 Manufacturing 161
17.1.2.2 Product Development 161
17.1.2.3
Sales and Marketing 163
17.1.3 Boston Scientific Corporation Pipeline
Products 164
17.1.3.1 Boston Scientific Corporation Pipeline Products By
Equipment Type 164
17.1.3.2 Boston Scientific Corporation Pipeline
Products By Development Stage 165
17.1.3.3 Boston Scientific Corporation
Pipeline Products By Therapy Area 166
17.1.3.4 Boston Scientific
Corporation Pipeline Products By Clinical Trials 167
17.1.3.5 Boston
Scientific Corporation Pipeline Products By News Summary 168
17.2
Medtronic, Inc. 169
17.2.1 Company Overview 169
17.2.2 Value Chain
Analysis 169
17.2.2.1 Manufacturing 169
17.2.2.2 Product Development
169
17.2.2.3 Sales and Marketing 170
17.2.3 Medtronic, Inc. Pipeline
Products 171
17.2.3.1 Medtronic, Inc. Pipeline Products By Equipment Type
171
17.2.3.2 Medtronic, Inc. Pipeline Products By Development Stage
173
17.2.3.3 Medtronic, Inc. Pipeline Products By Therapy Area 175
17.2.3.4 Medtronic, Inc. Pipeline Products By Clinical Trials 177
17.2.3.5
Medtronic, Inc. Pipeline Products By News Summary 178
17.3 Cordis
Corporation 179
17.3.1 Company Overview 179
17.3.2 Cordis Corporation
Pipeline Products 179
17.3.2.1 Cordis Corporation Pipeline Products By
Equipment Type 179
17.3.2.2 Cordis Corporation Pipeline Products By
Development Stage 180
17.3.2.3 Cordis Corporation Pipeline Products By
Therapy Area 180
17.3.2.4 Cordis Corporation Pipeline Products By Clinical
Trials 180
17.3.2.5 Cordis Corporation Pipeline Products By News Summary
181
17.4 Abbott Laboratories 181
17.4.1 Company Overview 181
17.4.2 Value Chain Analysis 182
17.4.2.1 Manufacturing 182
17.4.2.2
Product Development 182
17.4.2.3 Sales and Marketing 184
17.5 St. Jude
Medical, Inc. 184
17.5.1 Company Overview 184
17.5.2 Value Chain
Analysis 185
17.5.2.1 Manufacturing 185
17.5.2.2 Product Development
185
17.5.2.3 Sales and Marketing 186
17.5.3 St. Jude Medical Inc.
Pipeline Products 187
17.5.3.1 St. Jude Medical Inc. Pipeline Products By
Equipment Type 187
17.5.3.2 St. Jude Medical Inc. Pipeline Products By
Development Stage 188
17.5.3.3 St. Jude Medical Inc. Pipeline Products By
Therapy Area 189
17.5.3.4 St. Jude Medical Inc. Pipeline Products By
Clinical Trials 190
17.5.3.5 St. Jude Medical Inc. Pipeline Products By
News Summary 190
17.6 BIOTRONIK GmbH & Co. KG 191
17.6.1 Company
Overview 191
17.6.2 BIOTRONIK GmbH & Co. KG Pipeline Products 191
17.6.2.1 BIOTRONIK GmbH & Co. KG Pipeline Products By Equipment Type 191
17.6.2.2 BIOTRONIK GmbH & Co. KG Pipeline Products By Development Stage
191
17.6.2.3 BIOTRONIK GmbH & Co. KG Pipeline Products By Therapy Area
192
17.6.2.4 BIOTRONIK GmbH & Co. KG Pipeline Products By Clinical Trials
192
17.6.2.5 BIOTRONIK GmbH & Co. KG Pipeline Products By News Summary
192
17.7 Sorin S.p.A. 193
17.7.1 Company Overview 193
17.7.2 Value
Chain Analysis 193
17.7.2.1 Manufacturing 193
17.7.2.2 Product
Development 194
17.7.2.3 Sales and Marketing 196
17.7.3 Sorin Group
Pipeline Products 197
17.7.3.1 Sorin Group Pipeline Products By Equipment
Type 197
17.7.3.2 Sorin Group Pipeline Products By Development Stage
197
17.7.3.3 Sorin Group Pipeline Products By Therapy Area 198
17.7.3.4 Sorin Group Pipeline Products By Clinical Trials 198
17.7.3.5
Sorin Group Pipeline Products By News Summary 198
17.8 GE Healthcare
199
17.8.1 Company Overview 199
17.8.2 GE Healthcare Pipeline Products
199
17.8.2.1 GE Healthcare Pipeline Products By Equipment Type 199
17.8.2.2 GE Healthcare Pipeline Products By Development Stage 199
17.8.2.3
GE Healthcare Pipeline Products By Therapy Area 200
17.8.2.4 GE Healthcare
Pipeline Products By Clinical Trials 200
17.8.2.5 GE Healthcare Pipeline
Products By News Summary 200
17.9 Philips Healthcare 201
17.9.1
Company Overview 201
17.9.2 Value Chain Analysis 202
17.9.2.1
Manufacturing 202
17.9.2.2 Product Development 202
17.9.2.3 Sales and
Marketing 203
17.10 Cardiac Science Corporation 204
17.10.1 Company
Overview 204
17.10.2 Value Chain Analysis 205
17.10.2.1 Manufacturing
205
17.10.2.2 Product Development 205
17.10.2.3 Sales and Marketing
206
17.11 Nihon Kohden Corporation 207
17.11.1 Company Overview
207
17.11.2 Value Chain Analysis 208
17.11.2.1 Manufacturing 208
17.11.2.2 Product Development 208
17.11.2.3 Sales and Marketing 208
17.12 Edwards Lifesciences Corporation 209
17.12.1 Company Overview
209
17.12.2 Value Chain Analysis 209
17.12.2.1 Manufacturing 209
17.12.2.2 Product Development 209
17.12.2.3 Sales and Marketing 211
17.12.3 Edwards Lifesciences Corporation Pipeline Products 211
17.12.3.1
Edwards Lifesciences Corporation Pipeline Products By Equipment Type 211
17.12.3.2 Edwards Lifesciences Corporation Pipeline Products By Development
Stage 212
17.12.3.3 Edwards Lifesciences Corporation Pipeline Products By
Therapy Area 212
17.12.3.4 Edwards Lifesciences Corporation Pipeline
Products By Clinical Trials 213
17.12.3.5 Edwards Lifesciences Corporation
Pipeline Products By News Summary 213
17.13 MAQUET GmbH & Co. KG 214
17.13.1 Company Overview 214
17.14 Terumo Corporation 214
17.14.1
Company Overview 214
17.14.2 Value Chain Analysis 215
17.14.2.1
Manufacturing 215
17.14.2.2 Product Development 215
17.14.2.3 Sales
and Marketing 216
17.14.3 Terumo Corporation Pipeline Products 217
17.14.3.1 Terumo Corporation Pipeline Products By Equipment Type 217
17.14.3.2 Terumo Corporation Pipeline Products By Development Stage 217
17.14.3.3 Terumo Corporation Pipeline Products By Therapy Area 217
17.14.3.4 Terumo Corporation Pipeline Products By Clinical Trials 217
17.14.3.5 Terumo Corporation Pipeline Products By News Summary 218
17.15
AtriCure, Inc. 219
17.15.1 Company Overview 219
17.15.1.1 AtriCure,
Inc. Pipeline Products 219
17.15.1.2 AtriCure, Inc. Pipeline Products By
Equipment Type 219
17.15.1.3 AtriCure, Inc. Pipeline Products By
Development Stage 219
17.15.1.4 AtriCure, Inc. Pipeline Products By
Therapy Area 220
17.15.1.5 AtriCure, Inc. Pipeline Products By Clinical
Trials 220
17.15.1.6 AtriCure, Inc. Pipeline Products By News Summary
220
17.16 ev3 Inc. 221
17.16.1 Company Overview 221
17.16.2 Value
Chain Analysis 222
17.16.2.1 Manufacturing 222
17.16.2.2 Product
Development 222
17.16.2.3 Sales and Marketing 223
17.16.3 ev3 Inc.
Pipeline Products 224
17.16.3.1 ev3 Inc. Pipeline ProductsBy Equipment
Type 224
17.16.3.2 ev3 Inc. Pipeline Products By Development Stage 224
17.16.3.3 ev3 Inc. Pipeline Products By Therapy Area 225
17.16.3.4 ev3
Inc. Pipeline Products By Clinical Trials 225
17.16.3.5 ev3 Inc. Pipeline
Products By News Summary 225
17.17 OSI Systems, Inc. 226
17.17.1
Company Overview 226
17.17.2 Value Chain Analysis 227
17.17.2.1
Manufacturing 227
17.17.2.2 Product Development 227
17.17.2.3 Sales
and Marketing 228
17.18 Datascope Corporation 228
17.18.1 Company
Overview 228
17.18.2 Value Chain Analysis 228
17.18.2.1 Manufacturing
228
17.18.2.2 Product Development 229
17.18.2.3 Sales and Marketing
230
17.19 ABIOMED, Inc. 231
17.19.1 Company Overview 231
17.19.2
Value Chain Analysis 231
17.19.2.1 Manufacturing 231
17.19.2.2 Product
Development 232
17.19.2.3 Sales and Marketing 233
17.19.3 ABIOMED,
Inc. Pipeline Products 233
17.19.3.1 ABIOMED, Inc. Pipeline Products By
Equipment Type 233
17.19.3.2 ABIOMED, Inc. Pipeline Products By
Development Stage 233
17.19.3.3 ABIOMED, Inc. Pipeline Products By Therapy
Area 234
17.19.3.4 ABIOMED, Inc. Pipeline Products By Clinical Trials
234
17.19.3.5 ABIOMED, Inc. Pipeline Products By News Summary 234
17.20 Thoratec Corporation 235
17.20.1 Company Overview 235
17.20.2
Value Chain Analysis 235
17.20.2.1 Manufacturing 235
17.20.2.2 Product
Development 236
17.20.2.3 Sales and Marketing 237
17.20.2.4 Thoratec
Corporation Pipeline Products 237
17.20.2.5 Thoratec Corporation Pipeline
Products By Equipment Type 237
17.20.2.6 Thoratec Corporation Pipeline
Products By Development Stage 238
17.20.2.7 Thoratec Corporation Pipeline
Products By Therapy Area 238
17.20.2.8 Thoratec Corporation Pipeline
Products By Clinical Trials 238
17.20.2.9 Thoratec Corporation Pipeline
Products By News Summary 238
17.21 C.R. Bard, Inc. 239
17.21.1 Company
Overview 239
17.21.2 Value Chain Analysis 239
17.21.2.1 Manufacturing
239
17.21.2.2 Product Development 239
17.21.2.3 Sales and Marketing
240
17.21.3 C.R. Bard, Inc. Pipeline Products 241
17.21.3.1 C.R. Bard,
Inc. Pipeline Products By Equipment Type 241
17.21.3.2 C.R. Bard, Inc.
Pipeline Products By Development Stage 241
17.21.3.3 C.R. Bard, Inc.
Pipeline Products By Therapy Area 242
17.21.3.4 C.R. Bard, Inc. Pipeline
Products By Clinical Trials 242
17.22 Arrow International, Inc. 243
17.22.1 Company Overview 243
17.22.2 Value Chain Analysis 244
17.22.2.1 Manufacturing 244
17.22.2.2 Product Development 244
17.22.2.3 Sales and Marketing 245
17.22.3 Arrow International, Inc.
Pipeline Products 246
17.22.3.1 Arrow International, Inc. Pipeline
Products By Equipment Type 246
17.22.3.2 Arrow International, Inc.
Pipeline Products By Development Stage 246
17.22.3.3 Arrow International,
Inc. Pipeline Products By Therapy Area 246
17.22.3.4 Arrow International,
Inc. Pipeline Products By Clinical Trials 246
17.23 Invatec S.r.l. 247
17.23.1 Company Overview 247
17.23.2 Invatec S.r.l. Pipeline Products
247
17.23.2.1 Invatec S.r.l. Pipeline Products By Equipment Type 247
17.23.2.2 Invatec S.r.l. Pipeline Products By Development Stage 248
17.23.2.3 Invatec S.r.l. Pipeline Products By Therapy Area 249
17.23.2.4
Invatec S.r.l. Pipeline Products By Clinical Trials 250
17.23.2.5 Invatec
S.r.l. Pipeline Products By News Summary 250
17.24 Fukuda Denshi Co., Ltd.
251
17.24.1 Company Overview 251
17.25 Welch Allyn Inc. 251
17.25.1 Company Overview 251
17.26 ST-Electromedicina, s.a 252
17.26.1
Company Overview 252
17.27 Biosense Webster, Inc. 252
17.27.1 Company
Overview 252
18 Recent Developments 253
18.1 Product News 253
18.1.1 May 20, 2009: Treatment of Complex Coronary Artery Disease with TAXUS
Express2 Stent System Found To Be More Cost Effective than Bypass Surgery in
SYNTAX Analysis 253
18.1.2 May 19, 2009: Cordis’ Nevo
Sirolimus-Eluting Coronary Stent Shows Superior Results In Comparison to Taxus
Liberte Stent 256
19 Appendix 258
19.1 GlobalData Research Methodology
258
19.2 Coverage 259
19.3 Secondary Research 260
19.4 Primary
Research 260
19.5 Models 261
19.6 Forecasts 261
19.7 Expert Panel
Validation 262
19.8 Currency Conversion 263
19.9 Contact Us 264
19.10 Disclaimer 264
1.1 List of Tables
Table 1: Number of
Doctors by Specialty in Spain, 2003-2007 34
Table 2: Number of Hospital
Wards by Specialty in Spain, 2003-2007 35
Table 3: Healthcare Institutions
in Spain, 2007 36
Table 4: Hospital Beds by Type in Spain, 2007 36
Table 5: Number of Healthcare Personnel in Spain, 2007 37
Table 6: Number
of Selected Medical Equipment in Spain, 2007 37
Table 7:
Cardiovascular Devices, Spain, Overall Revenue ($ m), Historic, 2000-2008
55
Table 8: Cardiovascular Devices, Spain, Overall Revenue ($ m),
Forecast, 2008-2015 57
Table 9: Cardiovascular Devices, Spain,
Category Volume (Units), Historic, 2000-2008 59
Table 10:
Cardiovascular Devices, Spain, Category Volume (Units), Forecast, 2008-2015
61
Table 11: Cardiovascular Devices, Spain, Cross-Category Analysis,
2000-2015 62
Table 12: Cardiovascular Devices, Spain, Company Share
by Revenue ($ m), 2007-2008 63
Table 13: Cardiac Rhythm Management,
Spain, Revenue ($ m) by Segment, Historic, 2000-2008 64
Table 14:
Cardiac Rhythm Management, Spain, Revenue ($ m) by Segment, Forecast,
2008-2015 65
Table 15: Cardiac Resynchronisation Therapy, Spain,
Revenue ($ m) by Sub-Segment, Historic, 2000-2008 67
Table 16:
Cardiac Resynchronisation Therapy, Spain, Revenue ($ m) by Sub-Segment,
Forecast, 2008-2015 68
Table 17: Implantable Cardioverter
Defibrillator, Spain, Revenue ($ m) by Sub-Segment, Historic, 2000-2008 69
Table 18: Implantable Cardioverter Defibrillator, Spain, Revenue ($ m) by
Sub-Segment, Forecast, 2008-2015 70
Table 19: Pacemaker, Spain,
Revenue ($ m) by Sub-Segment, Historic, 2000-2008 71
Table 20:
Pacemaker, Spain, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015 72
Table 21: Cardiac Rhythm Management, Spain, Volume (Units) by Segment,
Historic, 2000-2008 73
Table 22: Cardiac Rhythm Management, Spain,
Volume (Units) by Segment, Forecast, 2008-2015 74
Table 23: Cardiac
Resynchronisation Therapy, Spain, Volume (Units) by Sub-Segment, Historic,
2000-2008 75
Table 24: Cardiac Resynchronisation Therapy, Spain,
Volume (Units) by Sub-Segment, Forecast, 2008-2015 76
Table 25:
Implantable Cardioverter Defibrillator, Spain, Volume (Units) by Sub-Segment,
Historic, 2000-2008 77
Table 26: Implantable Cardioverter
Defibrillator, Spain, Volume (Units) by Sub-Segment, Forecast, 2008-2015
78
Table 27: Pacemaker, Spain, Volume (Units) by Sub-Segment,
Historic, 2000-2008 79
Table 28: Pacemaker, Spain, Volume (Units) by
Sub-Segment, Forecast, 2008-2015 80
Table 29: Cardiac Rhythm
Management, Spain, Average Price ($), Historic, 2000-2008 81
Table 30:
Cardiac Rhythm Management, Spain, Average Price ($), Forecast,, 2008-2015
81
Table 31: Cardiac Rhythm Management, Spain, Distribution Share by
Revenue ($mn), 2007-2008 83
Table 32: Cardiac Rhythm Management,
Spain, Company Share by Revenue ($ mn), 2007-2008 84
Table 33:
Cardiovascular Monitoring and Diagnostic Devices, Spain, Revenue ($ m) by
Segment, Historic, 2000-2008 85
Table 34: Cardiovascular Monitoring
and Diagnostic Devices, Spain, Revenue ($ m) by Segment, Forecast, 2008-2015
87
Table 35: Cardiovascular Monitoring and Diagnostic Devices, Spain,
Volume (Units) by Segment, Historic, 2000-2008 88
Table 36:
Cardiovascular Monitoring and Diagnostic Devices, Spain, Volume (Units) by
Segment, Forecast, 2008-2015 89
Table 37: Cardiovascular Monitoring
and Diagnostic Devices, Spain, Average Price ($), Historic, 2000-2008 90
Table 38: Cardiovascular Monitoring and Diagnostic Devices, Spain,
Average Price ($), Forecast,, 2008-2015 90
Table 39: Cardiovascular
Monitoring and Diagnostic Devices, Spain, Distribution Share by Revenue ($m),
2007-2008 92
Table 40: Cardiovascular Monitoring and Diagnostic
Devices, Spain, Company Share by Revenue ($ m), 2007-2008 93
Table 41:
Cardiovascular Prosthetic Devices, Spain, Revenue ($ m) by Segment, Historic,
2000-2008 94
Table 42: Cardiovascular Prosthetic Devices, Spain,
Revenue ($ m) by Segment, Forecast, 2008-2015 95
Table 43: Cardiac
Assist Devices, Spain, Revenue ($ m) by Sub-Segment, Historic, 2000-2008
97
Table 44: Cardiac Assist Devices, Spain, Revenue ($ m) by
Sub-Segment, Forecast, 2008-2015 98
Table 45: Prosthetic Heart Valve,
Spain, Revenue ($ m) by Sub-Segment, Historic, 2000-2008 99
Table 46:
Prosthetic Heart Valve, Spain, Revenue ($ m) by Sub-Segment, Forecast,
2008-2015 100
Table 47: Cardiovascular Prosthetic Devices, Spain,
Volume (Units) by Segment, Historic, 2000-2008 101
Table 48:
Cardiovascular Prosthetic Devices, Spain, Volume (Units) by Segment, Forecast,
2008-2015 102
Table 49: Cardiac Assist Devices, Spain, Volume (Units)
by Sub-Segment, Historic, 2000-2008 103
Table 50: Cardiac Assist
Devices, Spain, Volume (Units) by Sub-Segment, Forecast, 2008-2015 104
Table 51: Prosthetic Heart Valve, Spain, Volume (Units) by Sub-Segment,
Historic, 2000-2008 105
Table 52: Prosthetic Heart Valve, Spain,
Volume (Units) by Sub-Segment, Forecast, 2008-2015 106
Table 53:
Cardiovascular Prosthetic Devices, Spain, Average Price ($), Historic,
2000-2008 107
Table 54: Cardiovascular Prosthetic Devices, Spain,
Average Price ($), Forecast,, 2008-2015 107
Table 55: Cardiovascular
Prosthetic Devices, Spain, Distribution Share by Revenue ($m), 2007-2008
108
Table 56: Cardiovascular Prosthetic Devices, Spain, Company Share
by Revenue ($ m), 2007-2008 109
Table 57: Cardiovascular Surgery,
Spain, Revenue ($ m) by Segment, Historic, 2000-2008 110
Table 58:
Cardiovascular Surgery, Spain, Revenue ($ m) by Segment, Forecast, 2008-2015
111
Table 59: Perfusion Disposables, Spain, Revenue ($ m) by
Sub-Segment, Historic, 2000-2008 112
Table 60: Perfusion Disposables,
Spain, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015 113
Table 61:
Cardiovascular Surgery, Spain, Volume (Units) by Segment, Historic, 2000-2008
114
Table 62: Cardiovascular Surgery, Spain, Volume (Units) by
Segment, Forecast, 2008-2015 114
Table 63: Perfusion Disposables,
Spain, Volume (Units) by Sub-Segment, Historic, 2000-2008 115
Table 64:
Perfusion Disposables, Spain, Volume (Units) by Sub-Segment, Forecast,
2008-2015 116
Table 65: Cardiovascular Surgery, Spain, Average Price
($), Historic, 2000-2008 117
Table 66: Cardiovascular Surgery, Spain,
Average Price ($), Forecast,, 2008-2015 117
Table 67: Cardiovascular
Surgery, Spain, Distribution Share by Revenue ($m), 2007-2008 118
Table
68: Cardiovascular Surgery, Spain, Company Share by Revenue ($ m),
2007-2008 119
Table 69: Electrophysiology, Spain, Revenue ($ m) by
Segment, Historic, 2000-2008 120
Table 70: Electrophysiology, Spain,
Revenue ($ m) by Segment, Forecast, 2008-2015 121
Table 71:
Electrophysiology, Spain, Volume (Units) by Segment, Historic, 2000-2008
122
Table 72: Electrophysiology, Spain, Volume (Units) by Segment,
Forecast, 2008-2015 122
Table 73: Electrophysiology, Spain, Average
Price ($), Historic, 2000-2008 123
Table 74: Electrophysiology,
Spain, Average Price ($), Forecast,, 2008-2015 124
Table 75:
Electrophysiology, Spain, Distribution Share by Revenue ($m), 2007-2008
124
Table 76: Electrophysiology, Spain, Company Share by Revenue ($
m), 2007-2008 125
Table 77: Interventional Cardiology, Spain, Revenue
($ m) by Segment, Historic, 2000-2008 126
Table 78: Interventional
Cardiology, Spain, Revenue ($ m) by Segment, Forecast, 2008-2015 128
Table
79: Cardiac Catheter, Spain, Revenue ($ m) by Sub-Segment, Historic,
2000-2008 129
Table 80: Cardiac Catheter, Spain, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 130
Table 81: Coronary Stent, Spain,
Revenue ($ m) by Sub-Segment, Historic, 2000-2008 131
Table 82:
Coronary Stent, Spain, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015
132
Table 83: PTCA Balloon, Spain, Revenue ($ m) by Sub-Segment,
Historic, 2000-2008 133
Table 84: PTCA Balloon, Spain, Revenue ($ m)
by Sub-Segment, Forecast, 2008-2015 134
Table 85: Interventional
Cardiology, Spain, Volume (Units) by Segment, Historic, 2000-2008 135
Table 86: Interventional Cardiology, Spain, Volume (Units) by Segment,
Forecast, 2008-2015 136
Table 87: Cardiac Catheter, Spain, Volume
(Units) by Sub-Segment, Historic, 2000-2008 137
Table 88: Cardiac
Catheter, Spain, Volume (Units) by Sub-Segment, Forecast, 2008-2015 138
Table 89: Coronary Stent, Spain, Volume (Units) by Sub-Segment, Historic,
2000-2008 139
Table 90: Coronary Stent, Spain, Volume (Units) by
Sub-Segment, Forecast, 2008-2015 140
Table 91: PTCA Balloon, Spain,
Volume (Units) by Sub-Segment, Historic, 2000-2008 141
Table 92: PTCA
Balloon, Spain, Volume (Units) by Sub-Segment, Forecast, 2008-2015 142
Table 93: Interventional Cardiology, Spain, Average Price ($), Historic,
2000-2008 143
Table 94: Interventional Cardiology, Spain, Average
Price ($), Forecast,, 2008-2015 144
Table 95: Interventional
Cardiology, Spain, Distribution Share by Revenue ($m), 2007-2008 146
Table
96: Interventional Cardiology, Spain, Company Share by Revenue ($ m),
2007-2008 147
Table 97: Peripheral Vascular Devices, Spain, Revenue
($ m) by Segment, Historic, 2000-2008 149
Table 98: Peripheral
Vascular Devices, Spain, Revenue ($ m) by Segment, Forecast, 2008-2015 151
Table 99: Peripheral Vascular Devices, Spain, Volume (Units) by Segment,
Historic, 2000-2008 153
Table 100: Peripheral Vascular Devices,
Spain, Volume (Units) by Segment, Forecast, 2008-2015 155
Table 101:
Peripheral Vascular Devices, Spain, Average Price ($), Historic, 2000-2008
157
Table 102: Peripheral Vascular Devices, Spain, Average Price ($),
Forecast,, 2008-2015 157
Table 103: Peripheral Vascular Devices,
Spain, Distribution Share by Revenue ($m), 2007-2008 158
Table 104:
Peripheral Vascular Devices, Spain, Company Share by Revenue ($ m), 2007-2008
159
Table 105: Boston Scientific Corporation Pipeline Products by
Equipment Type 164
Table 106: Boston Scientific Corporation Pipeline
Products By Development Stage 165
Table 107: Boston Scientific
Corporation Pipeline Products By Therapy Area 166
Table 108: Boston
Scientific Corporation Pipeline Products By Clinical Trials 167
Table 109:
Boston Scientific Corporation Pipeline Products By News Summary 168
Table 110: Medtronic, Inc. Pipeline Products by Equipment Type 171
Table 111: Medtronic, Inc. Pipeline Products By Development Stage 173
Table 112: Medtronic, Inc. Pipeline Products By Therapy Area 175
Table 113: Medtronic, Inc. Pipeline Products By Clinical Trials 177
Table 114: Medtronic, Inc. Pipeline Products By News Summary 178
Table 115: Cordis Corporation Pipeline Products by Equipment Type 179
Table 116: Cordis Corporation Pipeline Products By Development Stage
180
Table 117: Cordis Corporation Pipeline Products By Therapy Area
180
Table 118: Cordis Corporation Pipeline Products By Clinical
Trials 180
Table 119: Cordis Corporation Pipeline Products By News
Summary 181
Table 120: St. Jude Medical Inc. Pipeline Products by
Equipment Type 187
Table 121: St. Jude Medical Inc. Pipeline Products
By Development Stage 188
Table 122: St. Jude Medical Inc. Pipeline
Products By Therapy Area 189
Table 123: St. Jude Medical Inc.
Pipeline Products By Clinical Trials 190
Table 124: St. Jude Medical
Inc. Pipeline Products By News Summary 190
Table 125: BIOTRONIK GmbH
& Co. KG Pipeline Products by Equipment Type 191
Table 126: BIOTRONIK
GmbH & Co. KG Pipeline Products By Development Stage 191
Table 127:
BIOTRONIK GmbH & Co. KG Pipeline Products By Therapy Area 192
Table 128:
BIOTRONIK GmbH & Co. KG Pipeline Products By Clinical Trials 192
Table
129: BIOTRONIK GmbH & Co. KG Pipeline Products By News Summary 192
Table 130: Sorin Group Pipeline Products by Equipment Type 197
Table
131: Sorin Group Pipeline Products By Development Stage 197
Table
132: Sorin Group Pipeline Products By Therapy Area 198
Table 133:
Sorin Group Pipeline Products By Clinical Trials 198
Table 134:
Sorin Group Pipeline Products By News Summary 198
Table 135: GE
Healthcare Pipeline Products by Equipment Type 199
Table 136: GE
Healthcare Pipeline Products By Development Stage 199
Table 137: GE
Healthcare Pipeline Products By Therapy Area 200
Table 138: GE
Healthcare Pipeline Products By Clinical Trials 200
Table 139: GE
Healthcare Pipeline Products By News Summary 200
Table 140: Edwards
Lifesciences Corporation Pipeline Products by Equipment Type 211
Table
141: Edwards Lifesciences Corporation Pipeline Products By Development
Stage 212
Table 142: Edwards Lifesciences Corporation Pipeline
Products By Therapy Area 212
Table 143: Edwards Lifesciences
Corporation Pipeline Products By Clinical Trials 213
Table 144:
Edwards Lifesciences Corporation Pipeline Products By News Summary 213
Table 145: Terumo Corporation Pipeline Products by Equipment Type 217
Table 146: Terumo Corporation Pipeline Products By Development Stage
217
Table 147: Terumo Corporation Pipeline Products By Therapy Area
217
Table 148: Terumo Corporation Pipeline Products By Clinical
Trials 217
Table 149: Terumo Corporation Pipeline Products By News
Summary 218
Table 150: AtriCure, Inc. Pipeline Products by Equipment
Type 219
Table 151: AtriCure, Inc. Pipeline Products By Development
Stage 219
Table 152: AtriCure, Inc. Pipeline Products By Therapy Area
220
Table 153: AtriCure, Inc. Pipeline Products By Clinical Trials
220
Table 154: AtriCure, Inc. Pipeline Products By News Summary
220
Table 155: ev3 Inc. Pipeline Products by Equipment Type 224
Table 156: ev3 Inc. Pipeline Products By Development Stage 224
Table
157: ev3 Inc. Pipeline Products By Therapy Area 225
Table 158:
ev3 Inc. Pipeline Products By Clinical Trials 225
Table 159: ev3 Inc.
Pipeline Products By News Summary 225
Table 160: ABIOMED, Inc.
Pipeline Products by Equipment Type 233
Table 161: ABIOMED, Inc.
Pipeline Products By Development Stage 233
Table 162: ABIOMED, Inc.
Pipeline Products By Therapy Area 234
Table 163: ABIOMED, Inc.
Pipeline Products By Clinical Trials 234
Table 164: ABIOMED, Inc.
Pipeline Products By News Summary 234
Table 165: Thoratec Corporation
Pipeli
|
Related Report
|
View Cart
